Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker CCCC
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Sep 29, 2026 | 12746238 Selected compounds for targeted degradation of BRD9 | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 8, 2026 | 12729193 Tricyclic ligands for degradation of IKZF2 or IKZF4 | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 1, 2026 | 12721852 Advantageous therapies for disorders mediated by Ikaros or Aiolos | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Jun 23, 2026 | 12662488 Spirocyclic compounds | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Jun 23, 2026 | 12661410 Compounds for targeted degradation of RET | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Apr 21, 2026 | 12605450 C3-carbon linked glutarimide Degronimers for target protein degradati… | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 10, 2026 | 12570626 Degraders and degrons for targeted protein degradation | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 24, 2026 | 12559492 BRAF degraders | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 2, 2025 | 12486290 Isoindolinone and indazole compounds for the degradation of EGFR | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 2, 2025 | 12486253 Therapeutics for the degradation of mutant BRAF | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Oct 14, 2025 | 12441740 N/O-linked degrons and degronimers for protein degradation | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 23, 2025 | 12421220 Bicyclic-substituted glutarimide cereblon binders | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 29, 2025 | 12371442 Isoindolinone and indazole compounds for the degradation of EGFR | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 22, 2025 | 12365681 Dihydrobenzimidazolones for medical treatment | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 18, 2025 | 12227504 Spirocyclic compounds | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 31, 2024 | 12180225 N/O-linked degrons and degronimers for protein degradation | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 3, 2024 | 12157735 Compounds for targeted degradation of BRD9 | CCCC C4 Therapeutics, Inc. | utility | Google Patents ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:39 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances